PT Jayamas Medica Industri Tbk

omed

Overview

OMED Overview

PT Jayamas Medica Industri Tbk is an Indonesia-based company, which is engaged in manufacturing of disposable medical devices under the One Med brand. The Company's segments include Manufacturing, Distribution and Retail. The Manufacturing segment is involved in the manufacture of medical supplies and equipment. The Distribution segment is involved with the large-scale distribution of medical supplies and equipment at strategic locations. The Retail segment is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. Its products category includes medical disposables and consumables, antiseptic and dialysis, diagnostics and equipment’s, walking aids and rehabilitation care, biotechnology and laboratory, and hospital furniture’s. Antiseptics and disinfectants are both used as germ-killing cleaning fluids in both health and daily use. Its subsidiaries include PT Intisumber Hasil Sempurna Global (IHSG) and PT Inti Medicom Retailindo.

24681012ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: OMED

Main
Market Cap.
IDR 5.33Trillion

~$339.26M USD

Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies & Distributions
Sector
Healthcare

Valuation

OMED Valuation Metrics

197

IDR

Closing Price on 2024-04-05

Price to Equity

23.78

P/E

At 23.78x P/E TTM, OMED.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Price to Book

2.50

P/B

At 2.50x P/B TTM, OMED.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 1.8x).

Price to Sales

3.27

P/S

At 3.27x P/S TTM, OMED.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Valuing PT Jayamas Medica Industri Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Jayamas Medica Industri Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
-60.00x
Price/Forward Earnings
-
Enterprise Value/Revenue
2.74x
Enterprise Value/EBITDA
13.89x
PEG Ratio
-

Analyst Ratings

No analyst ratings available yet.

Last closing: IDR1972024-04-05
IDR 125.51

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of OMED is IDR126, which is 35% lower than OMED's last closing price of IDR197 (as of 2024-04-05).

Valuation Recap of OMED stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 23.78x is above the ID market average of 8.22x but is trading in a P/E range similar to its peers in the Healthcare Equipment & Providers sector (23.78x).
Max 3
High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 2.50x is above the peers average of 1.80x in the Healthcare Equipment & Providers sector.
Max 3
Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 3.27x is similar to the peers average of 3.00x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of OMED's valuation relative to its current sales and future earnings growth.
Max 2
Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. OMED's P/CF ratio of -60.00x is considered healthy by analysts.●●
Max 2
Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. OMED's EV/R ratio of 2.74x is considered fairly underpriced by the market The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.98x. ●●
Max 3
Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of OMED is IDR 125.51, which is 35% lower than OMED's last closing price of IDR 197.00.
Max 3

Peers

OMED Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk68.46T27.18T 30.31T 2.96T 23.123.31
MIKAPT Mitra Keluarga Karyasehat Tbk.39.22T7.11T 4.13T 0.95T 41.297.01
SILOPT Siloam International Hospitals Tbk.32.40T10.75T 10.83T 1.11T 29.294.28
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.62T 2.35T -0.05T -433.0911.10
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk20.25T3.75T 3.61T 0.97T 20.865.94
HEALPT Medikaloka Hermina Tbk.19.03T8.52T 5.54T 0.48T 39.485.15
PRAYPT Famon Awal Bros Sedaya Tbk9.42T4.42T 1.70T 0.18T 53.643.42
TSPCTempo Scan Pacific Tbk9.09T11.31T 12.93T 1.41T 6.431.18
SOHOPT Soho Global Health Tbk6.24T4.67T 7.91T 0.34T 18.422.45
OMEDPT Jayamas Medica Industri Tbk5.33T2.46T 1.63T 0.22T 23.782.50
Competitiveness Recap of OMED stock
WeightNotesScore
High
At a market cap of IDR 5,330.58 billion, OMED.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.
Max 2
High
At a PE of 23.78, OMED.JK ranks 5 out of 10 companies in the Healthcare sector for P/E value. The average PE is -17.68 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. In this regard, it trails behind sector leaders such as PT Famon Awal Bros Sedaya Tbk (53.64) in the Healthcare sector.
Max 2
Medium
At a PE of 23.78, OMED.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 23.78). false
Max 2
Medium
At a revenue of IDR 1.63 trillion, OMED.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.
Max 2
Medium
At a profit of IDR 0.22 trillion, OMED.JK ranks 8 in Profit out of 10 companies in the Healthcare sector.
Max 2

Future

Future Growth of OMED

Growth Forecasts

No data available

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 23.68% against the IDX average of +12.0%.

Healthcare Equipment & Providers sector overview
No data is available for OMED at the moment.
Future growth prospect of OMED
WeightNotesScore
High
OMED's projected growth rate of 23.68% is above the ID market average of 11.98%.●●●
Max 3
High
The Healthcare Equipment & Providers sub-sector is projected to grow revenue by 22.97% in 2024. This number is higher than the previous year 2023's growth rate of 9.96%. This bodes well for OMED's revenue growth prospects in the next 2 years. ●●●
Max 3
Medium
The Healthcare Equipment & Providers sub-sector is projected to increase earnings by 29.75% in 2024. This number is higher than the previous year 2023's EPS growth of 9.77%. This bodes well for OMED's earnings growth prospects in the next 2 years. ●●●
Max 3
Medium
OMED and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a fruitful year heading into 2024. Specifically, earnings are projected to increase by 16.30% in 2024 while revenue growth is projected to increase by 17.10%. These macroeconomic trends will likely be a tailwind for OMED's earnings growth prospects in the next 2 years. ●●
Max 3
Loading...
Loading...

Management

Executive Management

President Director

Dra. Herlien Sri Ariani, Apt.15.2 years
Leonard Hariadi Hartanto
Director
Louis Krisnadi Hartanto
Director
Eka Suwignyoo
Director
NamePositionShares%
Siane SoetantoCommissioner230,000,0000.85
Yacobus Jemmy HartantoPresident Commissioner230,000,0000.85
Expressed in millions IDR, unless otherwise stated

Ownership

OMED Ownership

Others
14.5%
Insiders
85%
Institutions
0.5%
NameNumber of SharesOwnership (%)Value
Pt Intisumber Hasilsempurna22,540,000,00083.34,440.38B
Public (Scripless)4,058,850,00015799.59B
Siane Soetanto230,000,0000.8545.31B
Yacobus Jemmy Hartanto230,000,0000.8545.31B

Largest Institutional Buy

No data is available for OMED at the moment.

Largest Institutional Sell

Acadian Asset Management LLC
Sold 31-12-2023
-13,084,500 shares

Institutional Transactions

Tracking institutional transactions buying / selling of OMED stock